Literature DB >> 16632425

Prognostic value of the interpectoral lymph nodes in breast cancer. A 20-year survival study.

A García-Vilanova Comas1, A García Vilanova, E Fuster-Diana, N Martínez-Alzamora, Jm Fernández-Tena, J García-Vilanova Comas, M García-Vilanova Comas.   

Abstract

INTRODUCTION: The indication and extent of axillary lymph node dissection in breast cancer remains open to controversy. MATERIALS AND
METHOD: In this context, a 20-year survival study has been made of 1600 breast cancer patients subjected during surgical treatment to systematic dissection of the acromiothoracic vascular pedicle together with the accompanying lymph nodes (Rotter and Grossman interpectoral lymph node groups). An anatomical study of these nodes was also conducted in 100 necropsies, with the evaluation of 200 acromiothoracic vascular pedicles.
RESULTS: The interpectoral lymph nodes were anatomically present in 42% of the necropsies and in 35.1% of the patients subjected to surgery. The prognosis was much worse in cases of neoplastic infiltration of the interpectoral lymph nodes (Kaplan-Meier survival study), regardless of the influence of other prognostic factors.
CONCLUSIONS: In view of the results obtained, the designation of grade N3 of the TNM classification is proposed for malignancies with positive interpectoral lymph node infiltration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16632425     DOI: 10.1007/s12094-006-0167-9

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  27 in total

1.  Can interpectoral nodes be sentinel nodes?

Authors:  A Bale; B Gardner; M Shende; F Fromowitz
Journal:  Am J Surg       Date:  1999-11       Impact factor: 2.565

Review 2.  How should the axilla be treated in breast cancer? Why I favour axillary node clearance in the management of breast cancer.

Authors:  T Davidson
Journal:  Eur J Surg Oncol       Date:  1995-02       Impact factor: 4.424

Review 3.  How should the axilla be treated in breast cancer? Why I favour axillary node sampling in the management of breast cancer.

Authors:  M J Greenall
Journal:  Eur J Surg Oncol       Date:  1995-02       Impact factor: 4.424

4.  Prospective evaluation of clinical and pathologic detection of axillary metastases in patients with carcinoma of the breast.

Authors:  A H Chevinsky; J Ferrara; A G James; J P Minton; D Young; W B Farrar
Journal:  Surgery       Date:  1990-10       Impact factor: 3.982

5.  Extent of axillary dissection preceding irradiation for carcinoma of the breast.

Authors:  G F Schwartz; D M D'Ugo; A L Rosenberg
Journal:  Arch Surg       Date:  1986-12

6.  [Local and regional lymph node invasion in breast cancer].

Authors:  G Contesso; J Rouessé; J Genin
Journal:  Bull Cancer       Date:  1975 Oct-Dec       Impact factor: 1.276

7.  Interpectoral nodes in carcinoma of the breast: requiem or resurrection.

Authors:  R Y Chandawarkar; S R Shinde
Journal:  J Surg Oncol       Date:  1996-07       Impact factor: 3.454

8.  Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trial.

Authors:  U Veronesi; A Banfi; B Salvadori; A Luini; R Saccozzi; R Zucali; E Marubini; M Del Vecchio; P Boracchi; S Marchini
Journal:  Eur J Cancer       Date:  1990       Impact factor: 9.162

9.  Interpectoral nodes as the initial site of recurrence in breast cancer.

Authors:  Ian K Komenaka; Valerie P Bauer; Freya R Schnabel; Kathie-Ann Joseph; Elizabeth Horowitz; Beth-Ann Ditkoff; Mahmoud B El-Tamer
Journal:  Arch Surg       Date:  2004-02

10.  Lymphatic drainage patterns from the breast.

Authors:  Susanne H Estourgie; Omgo E Nieweg; Renato A Valdés Olmos; Emiel J Th Rutgers; Bin B R Kroon
Journal:  Ann Surg       Date:  2004-02       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.